Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Buy
13,367
+27
+0.2% +$2.56K 0.09% 198
2025
Q4
$1.27M Buy
13,340
+1,923
+17% +$226K 0.09% 185
2025
Q3
$1.49M Buy
11,417
+2,925
+34% +$353K 0.1% 171
2025
Q2
$958K Buy
8,492
+1,367
+19% +$142K 0.09% 213
2025
Q1
$661K Sell
7,125
-1,096
-13% -$111K 0.08% 223
2024
Q4
$878K Sell
8,221
-17,050
-67% -$1.86M 0.1% 197
2024
Q3
$2.61M Sell
25,271
-336
-1% -$31.6K 0.27% 105
2024
Q2
$2.26M Buy
25,607
+1,995
+8% +$182K 0.26% 110
2024
Q1
$2.32M Sell
23,612
-1,727
-7% -$156K 0.26% 114
2023
Q4
$2.34M Buy
25,339
+11,091
+78% +$941K 0.28% 114
2023
Q3
$1.18M Buy
14,248
+5,439
+62% +$469K 0.24% 118
2023
Q2
$746K Buy
8,809
+5,151
+141% +$422K 0.14% 147
2023
Q1
$308K Buy
3,658
+685
+23% +$59K 0.06% 189
2022
Q4
$252K Buy
2,973
+21
+0.7% +$1.65K 0.05% 179
2022
Q3
$202K Buy
+2,952
New +$209K 0.05% 193
2022
Q2
Sell
-2,749
Closed -$211K 200
2022
Q1
$211K Buy
+2,749
New +$202K 0.03% 184

Other funds holding ACM

IQ EQ Fund Management's ACM Position: Q1 2026 in Review

IQ EQ Fund Management increased its Aecom (ACM) stake by 0.2% in Q1 2026, buying an estimated $2.56K and bringing the position to 13,367 shares worth $1.13M. The position accounts for 0.09% of the portfolio, ranked #198.

IQ EQ Fund Management first reported a position in ACM in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.61M in Q3 2024. 618 funds tracked by Wall St. Rank hold ACM as of Q1 2026.

  • IQ EQ Fund Management held 13,367 shares of Aecom worth $1.13M as of Q1 2026.
  • IQ EQ Fund Management bought 27 Aecom shares in Q1 2026, an estimated $2.56K.
  • Aecom made up 0.09% of IQ EQ Fund Management's portfolio in Q1 2026, its #198 holding.
  • IQ EQ Fund Management first reported a position in Aecom in Q1 2022 and has held it in 16 quarters since.
  • IQ EQ Fund Management's Aecom position peaked at $2.61M in Q3 2024.
  • 618 funds tracked by Wall St. Rank held Aecom as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.